Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel

Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be needed to assess is expected to rapidly increase. This calls for the implementati...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarpa, Aldo, Sikora, Katarzyna, Fassan, Matteo, Rachiglio, Anna Maria, Cappellesso, Rocco, Antonello, Davide, Amato, Eliana, Mafficini, Andrea, Lambiase, Matilde, Esposito, Claudia, Bria, Emilio, Simonato, Francesca, Scardoni, Maria, Turri, Giona, Chilosi, Marco, Tortora, Giampaolo, Fassina, Ambrogio, Normanno, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827450/
https://www.ncbi.nlm.nih.gov/pubmed/24236184
http://dx.doi.org/10.1371/journal.pone.0080478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827450/
https://www.ncbi.nlm.nih.gov/pubmed/24236184
http://dx.doi.org/10.1371/journal.pone.0080478

Ejemplares similares